Emily Hicks is a pharmacist who is specialized in Ambulatory Care in Bedford, Indiana. Patients can reach her at 2900 16th St, Bedford or contact her on 812-278-8800. Active license number of Emily Hicks is 26024119A for Ambulatory Care in Indiana. Emily Hicks is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Emily Hicks speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Emily Hicks
Specialization:
Ambulatory Care
Credentials:
PHARMD
Gender:
Female
Location:
2900 16th St, Bedford, Indiana, 47421-3510
Phone:
812-278-8800
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Emily Hicks are as mentioned below.
NPI Number:
1619518867
NPI Enumeration Date:
30 Sep, 2019
NPI Last Update On:
30 Sep, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Hicks are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
26024119A
Indiana
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2900 16th St, Bedford, Indiana
Zip:
47421-3510
Phone Number:
--
Fax Number:
--
Patients can reach Emily Hicks at 2900 16th St, Bedford, Indiana or can call on phone at 812-278-8800.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.